These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 23416030)
1. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study. Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030 [TBL] [Abstract][Full Text] [Related]
2. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors. Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920 [TBL] [Abstract][Full Text] [Related]
3. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not. Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308 [TBL] [Abstract][Full Text] [Related]
4. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors. Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011 [TBL] [Abstract][Full Text] [Related]
5. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. Xu H; Bourne PA; Spaulding BO; Wang HL Hum Pathol; 2007 Apr; 38(4):555-63. PubMed ID: 17316760 [TBL] [Abstract][Full Text] [Related]
6. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications. Cagle PT; el-Naggar AK; Xu HJ; Hu SX; Benedict WF Am J Pathol; 1997 Feb; 150(2):393-400. PubMed ID: 9033254 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. Sica G; Wagner PL; Altorki N; Port J; Lee PC; Vazquez MF; Saqi A Arch Pathol Lab Med; 2008 Dec; 132(12):1889-95. PubMed ID: 19061285 [TBL] [Abstract][Full Text] [Related]
8. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis. Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas. Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410 [TBL] [Abstract][Full Text] [Related]
10. P63 expression in lung carcinoma: a tissue microarray study of 408 cases. Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738 [TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Swarts DR; Ramaekers FC; Speel EJ Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738 [TBL] [Abstract][Full Text] [Related]
12. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas. Yoshimoto T; Motoi N; Yamamoto N; Nagano H; Ushijima M; Matsuura M; Okumura S; Yamaguchi T; Fukayama M; Ishikawa Y Neuroendocrinology; 2018; 106(1):47-57. PubMed ID: 28208131 [TBL] [Abstract][Full Text] [Related]
14. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors. D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070 [TBL] [Abstract][Full Text] [Related]
15. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Jiang SX; Kameya T; Asamura H; Umezawa A; Sato Y; Shinada J; Kawakubo Y; Igarashi T; Nagai K; Okayasu I Mod Pathol; 2004 Feb; 17(2):222-9. PubMed ID: 14657947 [TBL] [Abstract][Full Text] [Related]